Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddie Reed

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2012
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?Rodney P Rocconi, Paula Sullivan, Beverly Long, et al.
The Journal of Biological Chemistry|July 23, 2004
ATM-dependent CHK2 activation induced by anticancer agent, irofulvenJian Wang, Timothy Wiltshire, Yutian Wang, et al.
International Journal of Oncology|July 6, 2007
In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinomaJinshun Zhao, Qingdi Q Li, Baobo Zou, et al.
International Journal of Molecular Medicine|July 16, 2004
Development and characterization of five cell models for chemoresistance studies of human ovarian carcinomaLi Li, Yingzi Luan, Gangduo Wang, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapyHuyen Pham, Benjamin M Schwartz, James E Delmore, et al.
BMJ Open|January 8, 2013
Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?Rui Gao, Kelie M Reece, Tristan Sissung, et al.
Plos One|June 5, 2014
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancerRitu Arora, Clayton Yates, Bernard D Gary, et al.
International Journal of Molecular Medicine|January 5, 2006
Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosaJing Wang, Bei Hu, Minchao Xu, et al.
Gynecologic Oncology|May 7, 2014
Validation of a venous thromboembolism risk assessment model in gynecologic oncologyWilliam Stroud, Jenny M Whitworth, Margaret Miklic, et al.
World Journal of Urology|December 14, 2004
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancerWilliam D Figg, Michael E Franks, David Venzon, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2012
Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?Rodney P Rocconi, Paula Sullivan, Beverly Long, et al.
The Journal of Biological Chemistry|July 23, 2004
ATM-dependent CHK2 activation induced by anticancer agent, irofulvenJian Wang, Timothy Wiltshire, Yutian Wang, et al.
International Journal of Oncology|July 6, 2007
In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinomaJinshun Zhao, Qingdi Q Li, Baobo Zou, et al.
International Journal of Molecular Medicine|July 16, 2004
Development and characterization of five cell models for chemoresistance studies of human ovarian carcinomaLi Li, Yingzi Luan, Gangduo Wang, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapyHuyen Pham, Benjamin M Schwartz, James E Delmore, et al.
BMJ Open|January 8, 2013
Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?Rui Gao, Kelie M Reece, Tristan Sissung, et al.
Plos One|June 5, 2014
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancerRitu Arora, Clayton Yates, Bernard D Gary, et al.
International Journal of Molecular Medicine|January 5, 2006
Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosaJing Wang, Bei Hu, Minchao Xu, et al.
Gynecologic Oncology|May 7, 2014
Validation of a venous thromboembolism risk assessment model in gynecologic oncologyWilliam Stroud, Jenny M Whitworth, Margaret Miklic, et al.
World Journal of Urology|December 14, 2004
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancerWilliam D Figg, Michael E Franks, David Venzon, et al.
Pageof 9